Isofol Medical Financials
| ISOFOL Stock | SEK 1.01 0.07 7.45% |
Isofol |
Understanding current and past Isofol Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Isofol Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Isofol Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Isofol Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Isofol Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Isofol Medical's management manipulating its earnings.
Isofol Medical Stock Summary
Isofol Medical competes with Infant Bacterial, Lipigon Pharmaceuticals, XSpray Pharma, Biovica International, and Oncopeptides. Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden. Isofol Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009581051 |
| Business Address | Biotech Center, Gothenburg, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | isofolmedical.com |
| Phone | 46 3 17 97 22 80 |
| Currency | SEK - Swedish Kronor |
You should never invest in Isofol Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Isofol Stock, because this is throwing your money away. Analyzing the key information contained in Isofol Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Isofol Medical Key Financial Ratios
Isofol Medical's financial ratios allow both analysts and investors to convert raw data from Isofol Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Isofol Medical over time and compare it to other companies across industries.Isofol Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Isofol Medical's current stock value. Our valuation model uses many indicators to compare Isofol Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Isofol Medical competition to find correlations between indicators driving Isofol Medical's intrinsic value. More Info.Isofol Medical AB is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Isofol Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Isofol Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Isofol Medical AB Systematic Risk
Isofol Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Isofol Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Isofol Medical AB correlated with the market. If Beta is less than 0 Isofol Medical generally moves in the opposite direction as compared to the market. If Isofol Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Isofol Medical AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Isofol Medical is generally in the same direction as the market. If Beta > 1 Isofol Medical moves generally in the same direction as, but more than the movement of the benchmark.
Isofol Medical Thematic Clasifications
Isofol Medical AB is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Isofol Medical July 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Isofol Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Isofol Medical AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Isofol Medical AB based on widely used predictive technical indicators. In general, we focus on analyzing Isofol Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Isofol Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 26.6 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 7.45 |
Complementary Tools for Isofol Stock analysis
When running Isofol Medical's price analysis, check to measure Isofol Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isofol Medical is operating at the current time. Most of Isofol Medical's value examination focuses on studying past and present price action to predict the probability of Isofol Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isofol Medical's price. Additionally, you may evaluate how the addition of Isofol Medical to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |